Download Files:
Carteolol hydrochloride
SKU
HY-17495A-100 mg
Category Reference compound
Tags Adrenergic Receptor, Cardiovascular Disease; Endocrinology, GPCR/G Protein;Neuronal Signaling
$90 – $140
Products Details
Product Description
– Carteolol hydrochloride (OPC-1085 hydrochloride) is a non-selective beta blocker used to treat glaucoma.
Web ID
– HY-17495A
Storage Temperature
– 4°C (Powder, sealed storage, away from moisture)
Shipping
– Room Temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C16H25ClN2O3
Citations
– J Pharmaceut Biomed. 2020, 113870.|ACS Omega. August 8, 2022.
References
– [1]Kuwahara, K., et al., Carteolol hydrochloride protects human corneal epithelial cells from UVB-induced damage in vitro. Cornea, 2005. 24(2): p. 213-20.|[2]Trinquand, C., et al., [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study]. J Fr Ophtalmol, 2003. 26(2): p. 131-6.
CAS Number
– 51781-21-6
Molecular Weight
– 328.8343
Compound Purity
– 99.96
SMILES
– O=C1NC2=C(C(OCC(O)CNC(C)(C)C)=CC=C2)CC1.Cl
Clinical Information
– Launched
Research Area
– Cardiovascular Disease; Endocrinology
Solubility
– DMSO : 50 mg/mL (ultrasonic;warming;heat to 60°C)|H2O : ≥ 25 mg/mL
Target
– Adrenergic Receptor
Pathway
– GPCR/G Protein;Neuronal Signaling
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.